Zurück

Wählen Sie Ihre Region

Corporate

Europa:

Flagge Albanien Albanien Flagge Bosnien-Herzegowina Bosnien-Herzegowina Flagge Bulgarien Bulgarien Flagge Kroatien Kroatien Flagge Zypern Zypern Flagge Montenegro Montenegro Flagge Tschechien Tschechien Flagge Dänemark Dänemark Flagge Estland Estland Flagge Spanien Spanien Flagge Kosovo Kosovo Flagge Litauen Litauen Flagge Lettland Lettland Flagge Luxemburg Luxemburg Flagge Mazedonien Mazedonien Flagge Deutschland Deutschland Flagge Polen Polen Flagge Portugal Portugal Flagge Rumänien Rumänien Flagge Serbien Serbien Flagge Slowakei Slowakei Flagge Slowenien Slowenien Flagge Schweiz Schweiz Flagge Schweden Schweden Flagge Türkei Türkei Flagge Ungarn Ungarn Flagge Großbritannien Großbritannien Flagge Italien Italien

Asien:

Flagge UAE UAE Flagge Hong Kong Hong Kong Flagge Kuwait Kuwait Flagge Libanon Libanon

Afrika:

Flagge Südafrika Südafrika

Vereinbaren Sie ein Beratungsgespräch über Stammzellen

Mehr erfahren

Kontaktieren Sie uns noch heute!

Möchten Sie mehr über unsere Dienstleistungen erfahren? Füllen Sie das untenstehende Formular aus, und wir werden uns so schnell wie möglich mit Ihnen in Verbindung setzen, um Ihnen alle notwendigen Informationen zu geben und Ihre Fragen zu beantworten.

    Wir möchten Sie darauf hinweisen, dass die im Formular angegebenen personenbezogenen Daten von FamiCord Suisse mit Sitz in der Schweiz (BusinessPark Zug Sumpfstrasse 26, 6302 Zug) zur telefonischen Kontaktaufnahme im Zusammenhang mit der Erteilung von Serviceinformationen verarbeitet werden.

    Obraz

    Unsere
    Transplantationen

    Liste der Verwendungen von Stammzellen, die von den Laboren der FamiCord-Gruppe freigegeben wurden:

    Obraz
    Liste der Verwendungen von Stammzellen, die von den Laboren der FamiCord-Gruppe freigegeben wurden:
    Nr. Quelle Quellentyp Diagnose Medizinbereich Anwendungsjahr Therapie Land Alter des Empfängers
    1 Source Source type Diagnosis Medicine Area Application year Therapy Country Recipient age
    2 Skeletal Muscle Allogeneic – Related Duchenne Muscular Dystrophy (DMD) Genetic Disorder 2026 Experimental Therapy Poland 14
    3 Cord Tissue Allogeneic – Related Autism Neurology 2026 Experimental Therapy Slovakia 4
    4 Cord Tissue Autologous Autism Neurology 2026 Experimental Therapy Slovakia 4
    5 Cord Tissue Allogeneic – Unrelated Autism Neurology 2026 Experimental Therapy Poland 7,11
    6 Cord Tissue Allogeneic – Unrelated Autism Neurology 2026 Experimental Therapy Poland 5,3
    7 Cord Tissue Allogeneic – Unrelated Autism Neurology 2026 Experimental Therapy Poland 7,11
    8 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2026 Experimental Therapy Poland 3,11
    9 Cord Tissue Allogeneic – Unrelated Cartilage Lesions Orthopedics 2026 Experimental Therapy Poland 67,2
    10 Cord Tissue Allogeneic – Unrelated Cartilage Lesions Orthopedics 2026 Experimental Therapy Poland 50,7
    11 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2026 Experimental Therapy Poland 4,6
    12 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2026 Experimental Therapy Poland 6,5
    13 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2026 Experimental Therapy Poland 6,7
    14 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2026 Experimental Therapy Poland 6,5
    15 Cord Tissue Allogeneic – Unrelated GvHD Hematology 2026 Experimental Therapy Poland 2,9
    16 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2026 Experimental Therapy Poland 3,1
    17 Cord Tissue Allogeneic – Unrelated Cartilage Lesions Orthopedics 2026 Experimental Therapy Poland 60,7
    18 Cord Tissue Allogeneic – Unrelated GvHD Hematology 2026 Experimental Therapy Poland 5,5
    19 Cord Tissue Allogeneic Autism Neurology 2026 Experimental Therapy United Arab Emirates 6
    20 Cord Tissue Allogeneic – Unrelated GvHD Hematology 2026 Experimental Therapy Poland 4,1
    21 Cord Tissue Allogeneic – Unrelated Cerebral palsy Neurology 2026 Experimental Therapy Poland 4,9
    22 Cord Tissue Allogeneic – Unrelated Autism Neurology 2026 Experimental Therapy Poland 8,7
    23 Cord Tissue Allogeneic – Unrelated Cerebral palsy Neurology 2026 Experimental Therapy Poland 3,2
    24 Cord Tissue Autologous Cerebral Palsy Neurology 2026 Experimental Therapy Slovakia 2
    25 Cord Tissue Allogeneic – Related Autism Neurology 2026 Experimental Therapy Slovakia 6
    26 Cord Tissue Allogeneic – Related Autism Neurology 2026 Experimental Therapy Slovakia 13
    27 Cord Tissue Allogeneic – Related Autism Neurology 2026 Experimental Therapy Slovakia 8
    28 Cord Tissue Allogeneic – Related Autism Neurology 2026 Experimental Therapy Slovakia 9
    29 Cord Tissue Autologous Autism Neurology 2026 Experimental Therapy Slovakia 8
    30 Cord Tissue Autologous Autism Neurology 2026 Experimental Therapy Slovakia 5
    31 Cord Tissue Autologous Autism Neurology 2026 Experimental Therapy Slovakia 3
    32 Cord Tissue Allogeneic – Related Autism Neurology 2026 Experimental Therapy Slovakia 3
    33 Cord Tissue Allogeneic – Unrelated Autism Neurology 2026 Experimental Therapy Poland 7,1
    34 Cord Tissue Allogeneic – Unrelated Optic Atrophy Ophthalmology 2026 Experimental Therapy Poland 76,3
    35 Cord Tissue Allogeneic – Unrelated Encephalitis, Myelitis Neurology 2026 Experimental Therapy Poland 36,6
    36 Cord Tissue Allogeneic – Unrelated Stress Incontinence Urology 2026 Experimental Therapy Poland 62,4
    37 Cord Tissue Allogeneic – Unrelated aGvHD, PNH Hematology 2026 Experimental Therapy Poland 17,8
    38 Cord Tissue Allogeneic – Unrelated Progressive Bulbar Palsy Neurology 2026 Experimental Therapy Poland 58,1
    39 Cord Tissue Allogeneic – Unrelated Autism Neurology 2026 Experimental Therapy Poland 6,2
    40 Cord Tissue Allogeneic – Unrelated Spinocerebellar Ataxia Neurology 2026 Experimental Therapy Poland 59,4
    41 Cord Tissue Allogeneic – Unrelated aGvHD Hematology 2026 Experimental Therapy Poland 15,5
    42 Cord Tissue Allogeneic – Unrelated aGvHD Hematology 2026 Experimental Therapy Poland 12,1
    43 Cord Tissue Allogeneic – Unrelated aGvHD Hematology 2026 Experimental Therapy Poland 10
    44 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Poland 4,6
    45 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Poland 8,9
    46 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Poland 5,2
    47 Cord Blood Allogeneic – Unrelated Acute Leukemia in remission, Pancytopenia after treatment Hematology 2026 Standard Therapy Denmark 18, 6
    48 Cord Blood Allogeneic – Related Juvenile Myelomonocytic Leukemia (JMML) Hematology 2026 Standard Therapy Germany 10, 10
    49 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Poland 6,9
    50 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Poland 7,2
    51 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Poland 5,5
    52 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Poland 4,1
    53 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Poland 8,6
    54 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Slovakia 7,6
    55 Cord Blood Allogeneic Thalassemia Major Hematology 2026 Standard Therapy Turkey 7,8
    56 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Poland 8,9
    57 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Slovakia 4,5
    58 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Poland 3,5
    59 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Slovakia 8
    60 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Slovakia 5
    61 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Slovakia 3
    62 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Poland 6,5
    63 Cord Blood Allogeneic – Related Diamond-Blackfan Anemia (DBA) Hematology 2026 Standard Therapy Germany 10, 1
    64 Bone Marrow Family Allogeneic T-Cell Lymphoma Hematology 2026 Standard Therapy Netherlands 65
    65 Bone Marrow Family Allogeneic Other Malignancy Hematology 2026 Standard Therapy France 51
    66 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Italy 27
    67 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy France 14
    68 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy France 68
    69 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy United Kingdom 43
    70 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy USA 68
    71 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy USA 69
    72 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Germany 67
    73 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy USA 64
    74 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy USA 73
    75 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy United Kingdom 26
    76 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy USA 74
    77 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Netherlands 66
    78 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Romania 25
    79 Bone Marrow Family Allogeneic Other Myelofibrosis/Myelosclerosis Hematology 2026 Standard Therapy USA 65
    80 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy Poland 62
    81 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Germany 63
    82 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Netherlands 47
    83 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Czechia 67
    84 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Sweden 74
    85 Bone Marrow Family Allogeneic Non-Hodgkin Lymphoma Hematology 2026 Standard Therapy Germany 72
    86 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Ukraine 40
    87 Bone Marrow Family Allogeneic No Data Hematology 2026 Standard Therapy Germany 70
    88 Bone Marrow Family Allogeneic Acute Lymphoblastic Leukemia Hematology 2026 Standard Therapy Hungary 35
    89 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy USA 71
    90 Bone Marrow Family Allogeneic Primary Myelofibrosis Hematology 2026 Standard Therapy Poland 37
    91 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy France 68
    92 Bone Marrow Family Allogeneic Fanconi Anemia Hematology 2026 Standard Therapy Germany 4
    93 Bone Marrow Family Allogeneic Acute Myeloid Leukemia (Relapse) Hematology 2026 Standard Therapy Germany 66
    94 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy Germany 70
    95 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy France 42
    96 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Netherlands 57
    97 Bone Marrow Family Allogeneic Polycythaemia Vera Hematology 2026 Standard Therapy Germany 61
    98 Bone Marrow Family Allogeneic CMML – Beginning Relapse Hematology 2026 Standard Therapy Netherlands 63
    99 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Australia 64
    100 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Poland 76